Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
June 13, 2026Neurology

Rescue Treatment of Inebilizumab in Refractory Myasthenia Gravis: A Case Report (P11-9.004)

View Full Paper
Ask AI
Bookmark
Share

Authors

QJQilong JiangLHLiqing HuCZChaoyue Zhang

Discussion

Loading...

Member takes

Overview

Case report shows efficacy and safety of Inebilizumab treatment in refractory myasthenia gravis, suggesting a new option for management.

Key Points

  • This report aims to evaluate the effectiveness and safety of Inebilizumab as a rescue treatment for refractory myasthenia gravis.
  • Case report of a patient with refractory myasthenia gravis receiving Inebilizumab
  • Evaluation of treatment efficacy and safety outcomes
  • Inebilizumab demonstrated positive efficacy in symptom management.
  • No significant safety concerns reported during the treatment.

Cite This Study

Jiang et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf32afaef96ed7f055a0chttps://doi.org/10.1212/wnl.0000000000216549
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Real-World Efficacy and Safety of Inebilizumab in Generalized Myasthenia Gravis (P9-9.014)2026
  2. 2Evaluating inebilizumab in the treatment of generalized myasthenia gravis2025 · 1 citations
  3. 3Evaluating inebilizumab in the treatment of generalized myasthenia gravis2025
  4. 4Management of Exacerbations and Rescue Therapy in the Phase 3 Myasthenia Gravis Inebilizumab Trial2026 · 1 citations
  5. 5Myasthenia Gravis Inebilizumab Trial (MINT): Efficacy, Pharmacodynamics, and Immunogenicity in AChR+ Cohort (Week 52) (S14.009)2026